Koers Cann American Corp. Other OTC
Aandelen
CNNA
US13764N2071
Farmaceutische producten
Omzet 2022 | - | Omzet 2023 | - | Marktkapitalisatie | 964K 901K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 10 mln. 9,34 mln. | Nettowinst (verlies) 2023 | 3 mln. 2,8 mln. | EV/omzet 2022 | - |
Nettoschuld 2022 | 202K 189K | Nettoschuld 2023 | 311K 291K | EV/omzet 2023 | - |
K/w-verhouding 2022 |
0,12
x | K/w-verhouding 2023 |
0,19
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 99% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jason Tucker
CEO | Chief Executive Officer | - | 01-02-23 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jason Tucker
CEO | Chief Executive Officer | - | 01-02-23 |
Pete Caruso
BRD | Director/Board Member | - | 01-03-23 |
Michael Kramer
BRD | Director/Board Member | - | 10-05-23 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+50,70% | 791 mld. | |
+41,96% | 630 mld. | |
-7,15% | 350 mld. | |
+18,77% | 328 mld. | |
+8,79% | 298 mld. | |
+18,02% | 246 mld. | |
+1,27% | 225 mld. | |
+11,95% | 218 mld. | |
+3,68% | 160 mld. |